Supply Chain
Medical device company ArthroCare announced Monday that it has reached an agreement in principle to settle an investors' class action lawsuit pending against the company and two of its former officers for $74 million.
Hospitals are expanding services, supplies and staff training programs to meet the needs of morbidly obese patients, according to a new report from healthcare supply contracting company Novation.
Makers of medical beds used in hospitals, nursing homes and patients' homes will see their best growth come from markets outside the United States and Europe, according to healthcare market research firm Kalorama Information.
Private equity firm Ancor Capital Partners announced Tuesday that it has acquired WellSpring Pharmaceutical Corporation, a manufacturer and marketer of specialty prescription and over-the-counter products. This is Ancor's fifteenth acquisition in the healthcare segment.
The growing drug shortage crisis is the number one supply chain concern for providers nationwide says Novation, a group purchasing organization. Yet, even in these dire circumstances, there may be a glimmer of hope.
The U.S. Department of Justice announced last week that medical device company Dfine has agreed to pay the United States $2.39 million to resolve allegations that it paid kickbacks to induce physicians to use its devices for treating spinal fractures.
Hopkins reduced 'red bag' regulated medical waste by 16 percent in part by putting appropriate trash in the correct containers.
With U.S. drug shortages reaching record numbers, President Obama issued an executive order on Monday, directing the FDA to take steps to reduce current shortages and prevent future disruptions.
Practice Greenhealth, a nonprofit organization working to help healthcare organizations improve their environmental practices, has released the Standardized Environmental Questions for Medical Products. The questions are designed to help hospitals identify, request and procure environmentally preferable medical products.
Struggling pharmaceutical giant AstraZeneca announced plans to lay off 400 employees at its main office in Wilmington, Delaware.